Literature DB >> 8883247

Hepatocellular carcinoma associated with precirrhotic primary biliary cirrhosis successfully treated by a right hepatic lobectomy: report of a case.

T Wakai1, Y Shirai, K Tsukada, T Aono, I Kurosaki, K Hatakeyama.   

Abstract

We report herein the case of a 69-year-old woman in whom hepatocellular carcinoma (HCC) arising in the precirrhotic phase of primary biliary cirrhosis (PBC) was successfully managed by a right hepatic lobectomy. The patient, who had never received a blood transfusion, had a 4-year history of asymptomatic PBC of Scheuer's histological classification stage II. Abdominal computed tomography (CT) revealed a mass measuring 4.0 cm in the right hepatic lobe, and a right hepatic lobectomy was performed in consideration of her good liver function and the deep location of the tumor in the right lobe. The patient has remained well without any evidence of recurrent disease for 4 years since her operation. A review of the literature revealed only two cases of successful partial hepatectomy, but none of major hepatectomy. Most of the reported cases had been treated with transcatheter arterial embolization (TAE) and were associated with poor survival. Our experience of this patient indicates the potential value of hepatectomy as an alternative to TAE in selected patients with resectable disease and good hepatic function.

Entities:  

Mesh:

Year:  1996        PMID: 8883247     DOI: 10.1007/bf00312093

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice).

Authors:  S SHERLOCK
Journal:  Gastroenterology       Date:  1959-11       Impact factor: 22.682

Review 2.  [Hepatocellular carcinoma complicating primary biliary cirrhosis--a case report and a review of the literature].

Authors:  H Takenawa; I Sakuma; K Yamaoka; M Yamane; K Shaura; H Sakai; T Ikeda; F Marumo; C Sato
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-11

3.  [Hepatocellular carcinoma and primary biliary cirrhosis: report of one case (author's transl)].

Authors:  L Mallet; J P Petite; D Amat; F Bloch; Y Juillet; J P Camilléri; E Housset
Journal:  Gastroenterol Clin Biol       Date:  1981-04

4.  [Hepatocellular carcinoma and primary biliary cirrhosis: a new case].

Authors:  G Terris; P de la Lande; P Vaury
Journal:  Gastroenterol Clin Biol       Date:  1982 Jun-Jul

5.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

6.  Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study.

Authors:  Y Nakanuma; T Terada; K Doishita; A Miwa
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

7.  Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases.

Authors:  N Krasner; P J Johnson; B Portmann; G Watkinson; R N Macsween; R Williams
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

8.  Hepatic resection versus transplantation for hepatocellular carcinoma.

Authors:  S Iwatsuki; T E Starzl; D G Sheahan; I Yokoyama; A J Demetris; S Todo; A G Tzakis; D H Van Thiel; B Carr; R Selby
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

9.  The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.

Authors:  J Roll; J L Boyer; D Barry; G Klatskin
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

10.  Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.

Authors:  W M Melia; P J Johnson; J Neuberger; S Zaman; B C Portmann; R Williams
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

View more
  1 in total

1.  Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: report of a case.

Authors:  T Morimoto; G Honda; Y Kawai; T Hirose; T Nishio; N Shinkura; Y Iimuro; N Yamamoto; Y Yamamoto; I Ikai; Y Shimahara; Y Yamaoka
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.